BeOne Medicines Insider Trades
NASDAQ: ONCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 84 · $221.69M
- Shares bought / sold
- 0 / 659.13K
- Net activity
- Net selling $221.7 million
BeOne Medicines insider activity
Over the last 12 months, BeOne Medicines insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 84 sales. Insiders bought $0 and sold $221.7 million worth of stock, for net insider selling of $221.7 million. The largest seller was OYLER JOHN, with $194.2 million in reported sales.
The most recent filing shows Lee Chan Henry (SVP, General Counsel) selling 1,115 shares at $375.00 on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ONC's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ONC insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | Lee Chan HenrySVP, General Counsel | Sale | 1,115 | $418.13K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 738 | $271.01K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 14,525 | $5.32M | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 2,047 | $748.89K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 3,419 | $1.24M | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 3,499 | $1.27M | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 4,239 | $1.54M | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 2,241 | $809.12K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 40 | $14.37K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 120 | $43.04K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Sale | 160 | $57.11K | Form 4 |
| Sep 28, 2026 | Wang XiaodongDirector | Option exercise | 31,028 | $1.14M | Form 4 |
| Sep 14, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Option exercise | 30,768 | $1.13M | Form 4 |
| Sep 14, 2026 | BAKER BROS. ADVISORS LP & 667, L.P. & Baker Bros. Advisors (GP) LLC & Baker Brothers Life Sciences LP & BAKER FELIX & BAKER JULIANDirector | Option exercise | 30,768 | $1.13M | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 6,278 | $2.21M | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 6,569 | $2.30M | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 10,688 | $3.73M | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 7,492 | $2.61M | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Option exercise | 31,027 | $1.14M | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 1,721 | $598.93K | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 1,517 | $526.99K | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 2,841 | $983.43K | Form 4 |
| Sep 8, 2026 | Wang XiaodongDirector | Sale | 1,181 | $407.90K | Form 4 |
| Sep 1, 2026 | Ball Titus B.Principal Accounting Officer | Sale | 132 | $46.97K | Form 4 |
| Aug 25, 2026 | Wu XiaobinPresident and COO | Sale | 280 | $106.40K | Form 4 |
| Aug 12, 2026 | OYLER JOHNChief Executive Officer | Sale | 14,102 | $5.06M | Form 4 |
| Aug 12, 2026 | OYLER JOHNChief Executive Officer | Sale | 20,899 | $7.49M | Form 4 |
| Aug 12, 2026 | OYLER JOHNChief Executive Officer | Sale | 15,396 | $5.51M | Form 4 |
| Aug 12, 2026 | OYLER JOHNChief Executive Officer | Sale | 2,515 | $896.43K | Form 4 |
| Aug 12, 2026 | OYLER JOHNChief Executive Officer | Sale | 1,980 | $702.32K | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 4 | $1.47K | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 1,200 | $439.57K | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 3,176 | $1.16M | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 5,211 | $1.90M | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 13,403 | $4.87M | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 11,568 | $4.19M | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 14,569 | $5.27M | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 8,081 | $2.91M | Form 4 |
| Aug 11, 2026 | OYLER JOHNChief Executive Officer | Sale | 13,695 | $4.92M | Form 4 |
| Aug 11, 2026 | Lee Chan HenrySVP, General Counsel | Sale | 2,666 | $959.76K | Form 4 |
| Aug 11, 2026 | Lee Chan HenrySVP, General Counsel | Option exercise | 796 | $126.59K | Form 4 |
| Aug 11, 2026 | Lee Chan HenrySVP, General Counsel | Option exercise | 1,058 | $225.69K | Form 4 |
| Aug 11, 2026 | Lee Chan HenrySVP, General Counsel | Option exercise | 812 | $157.91K | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 3,680 | $1.33M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 21,254 | $7.64M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 45,044 | $16.16M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 15,869 | $5.68M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 12,418 | $4.43M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 3,476 | $1.24M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 6,717 | $2.38M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 3,673 | $1.30M | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 2,813 | $989.60K | Form 4 |
| Aug 10, 2026 | OYLER JOHNChief Executive Officer | Sale | 67 | $23.45K | Form 4 |
| Aug 3, 2026 | Rosenberg AaronChief Financial Officer | Sale | 1,157 | $361.81K | Form 4 |
| Jul 30, 2026 | Lee Chan HenrySVP, General Counsel | Sale | 1,044 | $337.93K | Form 4 |
| Jul 22, 2026 | Lee Chan HenrySVP, General Counsel | Sale | 1,669 | $542.42K | Form 4 |
| Jul 22, 2026 | Lee Chan HenrySVP, General Counsel | Option exercise | 490 | $77.92K | Form 4 |
| Jul 22, 2026 | Lee Chan HenrySVP, General Counsel | Option exercise | 665 | $141.86K | Form 4 |
| Jul 22, 2026 | Lee Chan HenrySVP, General Counsel | Option exercise | 514 | $99.96K | Form 4 |
| Jul 21, 2026 | OYLER JOHNChief Executive Officer | Sale | 2,340 | $748.94K | Form 4 |
| Jul 21, 2026 | OYLER JOHNChief Executive Officer | Sale | 15,807 | $5.05M | Form 4 |
| Jul 21, 2026 | OYLER JOHNChief Executive Officer | Sale | 7,842 | $2.50M | Form 4 |
| Jul 21, 2026 | OYLER JOHNChief Executive Officer | Sale | 20,029 | $6.35M | Form 4 |
| Jul 21, 2026 | OYLER JOHNChief Executive Officer | Sale | 15,379 | $4.86M | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 280 | $89.12K | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 523 | $165.34K | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 1,512 | $476.68K | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 1,850 | $580.73K | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 14,326 | $4.48M | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 15,499 | $4.84M | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Option exercise | 33,990 | $4.08M | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 2,907 | $906.39K | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 6,273 | $1.95M | Form 4 |
| Jul 20, 2026 | OYLER JOHNChief Executive Officer | Sale | 5,146 | $1.60M | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 51 | $16.07K | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 740 | $232.60K | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 14,915 | $4.67M | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 35,829 | $11.18M | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 5,543 | $1.73M | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 4,833 | $1.50M | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 680 | $210.16K | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 597 | $183.26K | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Sale | 1,440 | $439.49K | Form 4 |
| Jul 17, 2026 | OYLER JOHNChief Executive Officer | Option exercise | 64,628 | $7.75M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 520 | $168.26K | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 1,560 | $503.42K | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 13,109 | $4.22M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 20,505 | $6.58M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 15,097 | $4.83M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 6,402 | $2.04M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 42,798 | $13.60M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 32,224 | $10.21M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 19,752 | $6.24M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 9,516 | $2.99M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 4,881 | $1.53M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Sale | 233 | $72.69K | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Option exercise | 70,096 | $8.41M | Form 4 |
| Jul 16, 2026 | OYLER JOHNChief Executive Officer | Option exercise | 96,501 | $15.48M | Form 4 |
| Jul 15, 2026 | OYLER JOHNChief Executive Officer | Option exercise | 76,677 | $13.00M | Form 4 |
| Jul 15, 2026 | OYLER JOHNChief Executive Officer | Option exercise | 35,605 | $3.56M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4